Qdenga

Centrally authorised medicine · European Medicines Agency · Germany

  • EMA product number EMEA/H/C/005155
  • ATC J07BX04

What the source publishes

Holder
Takeda Pharmaceuticals International AG Ireland Branch
Administrative status
authorised

Publisher documents

Names this record is found by

Complete source data
de:ema:epar:EMEA-H-C-005155
{
  "inn": "dengue tetravalent vaccine (live, attenuated)",
  "name": "Qdenga",
  "holder": "Takeda Pharmaceuticals International AG Ireland Branch",
  "orphan": false,
  "endDate": null,
  "generic": false,
  "smpcUrl": "https://www.ema.europa.eu/de/documents/product-information/qdenga-epar-product-information_de.pdf",
  "species": null,
  "atcCodes": [
    "J07BX04"
  ],
  "category": "Human",
  "marketed": null,
  "useDomain": "unknown",
  "biosimilar": false,
  "leafletUrl": "https://www.ema.europa.eu/de/documents/product-information/qdenga-epar-product-information_de.pdf",
  "medicineUrl": "https://www.ema.europa.eu/en/medicines/human/EPAR/qdenga",
  "decisionDate": "2026-09-03",
  "sourceStatus": "Authorised",
  "supplyRegime": null,
  "opinionStatus": null,
  "targetSpecies": [],
  "suspensionDate": null,
  "activeSubstance": "Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated;Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated;Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated;Dengue virus, serotype 2, live, attenuated",
  "advancedTherapy": false,
  "lastUpdatedDate": "2026-09-04",
  "reportTimestamp": "2026-11-08T18:01:45Z",
  "therapeuticArea": "Dengue",
  "emaProductNumber": "EMEA/H/C/005155",
  "authorisationDate": "2022-12-05",
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "de.ema.epar"
  },
  "patientEligibility": "not-assessed",
  "productInformation": {
    "url": "https://www.ema.europa.eu/de/documents/product-information/qdenga-epar-product-information_de.pdf",
    "language": "de",
    "updatedAt": "2026-09-04T12:15:00Z",
    "englishUrl": "https://www.ema.europa.eu/en/documents/product-information/qdenga-epar-product-information_en.pdf"
  },
  "conditionalApproval": false,
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": true,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "unknown",
  "exceptionalCircumstances": false,
  "pharmacotherapeuticGroup": "Vaccines"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=de" \
  --data-urlencode "sourceId=de.ema.epar" \
  --data-urlencode "id=de:ema:epar:EMEA-H-C-005155"